Author:
Kow Chia Siang,Ramachandram Dinesh Sangarran,Hasan Syed Shahzad
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Saygili ES, Karakiliç E, Mert E et al (2021) Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period [published online ahead of print, 2021 Oct 29]. Ir J Med Sci 1–7
2. Li Y, Yang X, Yan P et al (2021) Metformin in patients with COVID-19: a systematic review and meta-analysis. Front Med (Lausanne) 8:704666
3. Kan C, Zhang Y, Han F et al (2021) Mortality risk of antidiabetic agents for type 2 diabetes with COVID-19: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 12:708494
4. Poly TN, Islam MM, Li YJ et al (2021) Metformin use is associated with decreased mortality in COVID-19 patients with diabetes: evidence from retrospective studies and biological mechanism. J Clin Med 10(16):3507
5. Han T, Ma S, Sun C et al (2021) The association between anti-diabetic agents and clinical outcomes of COVID-19 in patients with diabetes: a systematic review and meta-analysis [published online ahead of print, 2021 Aug 9]. Arch Med Res S0188–4409(21):00167–3
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献